Results for:(80 found)
Aug 2, 2012 3:56PM on Top StocksBy Jim J. Jubak

Shares of a 3% dividend yield, solid blue-chip drug company are valuable in shaky economic times.

Aug 2, 2012 12:37PM on Top StocksBy MSN Money Partner

Stocks slide following the European Central Bank president's press conference.

Jul 3, 2012 11:45AM on Top StocksBy The Fiscal Times

A slew of recent M&A activity may give hope to investment banks.

Jul 2, 2012 2:35PM on Top StocksBy Minyanville

The transaction also includes a $3.4 billion payment from AstraZeneca as the big drug companies try to replace lost sales from products with generic competition.

Jul 2, 2012 12:53PM on Top StocksBy MSN Money Partner

Stocks dip as a key manufacturing index unexpectedly contracts for the first time in nearly 3 years.

Jul 2, 2012 8:38AM on Top StocksBy MSN Money Partner

The diabetes drugmaker is being acquired, and the chairman of the financial firm is resigning.

Jun 28, 2012 1:44PM on Top StocksBy Kim Peterson

Hospital stocks and Medicaid insurers saw big gains after the Supreme Court's ruling, while other health care stocks dropped.

Jun 27, 2012 8:52AM on Top StocksBy MSN Money Partner

The electronics retailers is reportedly a buyout candidate, and the media company will decide about splitting into 2.

VIDEO ON MSN MONEY

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.

MARKET DISPATCHES

No more Dispatches; here's where to find market news

The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.

More